Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2019-08-09
Original market date: See footnote 1
1988-12-31
Product name:
PANCREASE MT 16
DIN:
00789429
Product Monograph/Veterinary Labelling:
Date:
2023-09-05
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
VIVUS LLC.
900 East Hamilton Avenue, Suite 550
Campbell
California
United States
95008
Class:
Human
Dosage form(s):
Capsule (Delayed Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
3
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
56:16.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Active ingredient group (AIG) number:See footnote5
0302964030
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| AMYLASE | 70000 UNIT |
| LIPASE | 16800 UNIT |
| PROTEASE | 40000 UNIT |